ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
WHO, 2015. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. Geneva, Switzerland: World Health Organization. Available at: http://apps.who.int/iris/bitstream/10665/154590/1/9789241549059_eng.pdf?ua=1. Accessed March 16, 2015.
-
2.
Shimakawa Y, Lemoine M, Njai HF, Bottomley C, Ndow G, Goldin RD, Jatta A, Jeng-Barry A, Wegmuller R, Moore SE, 2015. Natural history of chronic HBV infection in west Africa: a longitudinal population-based study from The Gambia. Gut gutjnl-2015-309892.
-
3.
El-Serag H, 2011. Hepatocellular cancer. N Engl J Med 365: 1118–1127.
-
4.
Lemoine M, Eholié S, Lacombe K, 2015. Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach. J Hepatol 62: 469–476.
-
5.
Stockdale AJ, Geretti AM, 2015. Chronic hepatitis B infection in sub-Saharan Africa: a grave challenge and a great hope. Trans R Soc Trop Med Hyg 109: 421–422.
-
6.
Samuelsen H, 2001. Infusions of health: the popularity of vaccinations among Bissa in Burkina Faso. Anthropol Med 8: 163–175.
-
7.
Leach MA, Fairhead JR, Millimouno D, Diallo AA, 2008. New therapeutic landscapes in Africa: parental categories and practices in seeking infant health in the Republic of Guinea. Soc Sci Med 66: 2157–2167.
-
8.
Carruth L, 2014. Camel milk, amoxicillin, and a prayer: medical pluralism and medical humanitarian aid in the Somali Region of Ethiopia. Soc Sci Med 120: 405–412.
-
9.
Pourette D, Enel C, 2014. Représentations et vécu de l'hépatite B de patients subsahariens en Côte d'Ivoire et en France: representations and disease experience of hepatitis B by Sub-Saharan patients in Ivory Coast and France. Santé Publique 26: 869–878.
-
10.
Mkandawire P, Richmond C, Dixon J, Luginaah IN, Tobias J, 2013. Hepatitis B in Ghana's upper west region: a hidden epidemic in need of national policy attention. Health Place 23: 89–96.
-
11.
Blanas DA, Nichols K, Bekele M, Shankar H, Bekele S, Jandorf L, Izzeldin S, Ndiaye D, Traore A, Bassam M, 2015. Adapting the Andersen model to a francophone west African immigrant population: hepatitis B screening and linkage to care in New York City. J Community Health 40: 175–184.
-
12.
Cheng A, Jose J, Larsen-Reindorf R, Small C, Nde H, Dugas L, Ehrhardt S, Nelson K, Ezeanolue E, Layden J, 2015. A survey study of pregnant women and healthcare practitioners assessing the knowledge of attitudes and practices of hepatitis B management at a teaching hospital in Kumasi, Ghana, west Africa. Open Forum Infect Dis 2: ofv122.
-
13.
Pourette D, 2013. Prise en charge du VIH et de l'hépatite B chronique chez les migrants subsahariens en France: le rôle-clé de la relation médecin-patient. Santé Publique 25: 561–570.
-
14.
Abeje G, Azage M, 2015. Hepatitis B vaccine knowledge and vaccination status among health care workers of Bahir Dar City Administration, northwest Ethiopia: a cross sectional study. BMC Infect Dis 15: 1.
-
15.
Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ, 2015. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386: 1546–1555.
-
16.
Ridde V, Carabali M, Ly A, Druetz T, Kouanda S, Bonnet E, Haddad S, 2014. The need for more research and public health interventions on dengue fever in Burkina Faso. PLoS Negl Trop Dis 8: e2859.
-
17.
Ridde V, 2008. “The problem of the worst-off is dealt with after all other issues”: the equity and health policy implementation gap in Burkina Faso. Soc Sci Med 66: 1368–1378.
-
18.
INSD, 2013. Population Des Principales Villes. Available at: http://www.insd.bf/n/contenu/Tableaux/T0314.htm. Accessed December 20, 2015.
-
19.
INSD, 2013. Annuaire Statistique. Ouagadougou: Ministère de l'Économie et des Finances. Available at: http://www.insd.bf/n/contenu/pub_periodiques/annuaires_stat/Annuaires_stat_nationaux_BF/Annuaire_stat_2013.pdf. Accessed December 20, 2015.
-
20.
Bonnard P, Sombié R, Lescure F-X, Bougouma A, Guiard-Schmid JB, Poynard T, Calès P, Housset C, Callard P, Le Pendeven C, 2010. Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso. Am J Trop Med Hyg 82: 454–458.
-
21.
Charmaz K, 2006. Constructing Grounded Theory: A Practical Guide Through Qualitative Analysis London: Sage.
-
22.
Giles-Vernick T, Traore A, Sirima SB, 2011. Malaria, environmental change, and a historical epidemiology of childhood ‘cold fevers’: popular interpretations from southwestern Burkina Faso. Health Place 17: 836–842.
-
23.
Dugas M, Dubé E, Bibeau G, 2009. Translating malaria as sumaya: justified convention or inappropriateness? Anthropol Med 16: 307–318.
-
24.
World Bank, 2015. World Development Report. Available at: http://data.worldbank.org/country/burkina-faso. Accessed March 18, 2016.
-
25.
Gulliford M, Figueroa-Munoz J, Morgan M, Hughes D, Gibson B, Beech R, Hudson M, 2002. What does ‘access to health care' mean? J Health Serv Res Policy 7: 186–188.
-
26.
Debes J, Kayandabila J, Pogemiller H, 2016. Knowledge of hepatitis B transmission risks among health workers in Tanzania. Am J Trop Med Hyg 94: 1100–1102.
-
27.
Fontein J, 2011. Graves, ruins, and belonging: towards an anthropology of proximity. J R Anthropol Inst 17: 706–727.
-
28.
Brown H, Kelly AH, 2014. Material proximities and hotspots: toward an anthropology of viral hemorrhagic fevers. Med Anthropol Q 28: 280–303.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 438 | 358 | 32 |
| Full Text Views | 576 | 14 | 1 |
| PDF Downloads | 204 | 11 | 1 |
Barriers to Linkage to Care for Hepatitis B Virus Infection: A Qualitative Analysis in Burkina Faso, West Africa
Tamara Giles-Vernick
Tamara Giles-Vernick
Emerging Diseases Epidemiology Unit, Pasteur Institute, Paris, France.
Search for other papers by Tamara Giles-Vernick in
Current site
Google Scholar
PubMed
Search for other papers by Tamara Giles-Vernick in
Current site
Google Scholar
PubMed
Fabienne Hejoaka
Fabienne Hejoaka
Unité Mixte Internationale (UMI) 233/U1175 TransVIH, Institut de Recherche pour le Développement/Institut National de la Santé et de la Recherche Médicale (INSERM), Montpellier, France.
Centre de Recherche sur les Médiations, Université de Lorraine, Metz, France.
Search for other papers by Fabienne Hejoaka in
Current site
Google Scholar
PubMed
Centre de Recherche sur les Médiations, Université de Lorraine, Metz, France.
Search for other papers by Fabienne Hejoaka in
Current site
Google Scholar
PubMed
Armande Sanou
Armande Sanou
Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
Search for other papers by Armande Sanou in
Current site
Google Scholar
PubMed
Search for other papers by Armande Sanou in
Current site
Google Scholar
PubMed
Yusuke Shimakawa
Yusuke Shimakawa
Emerging Diseases Epidemiology Unit, Pasteur Institute, Paris, France.
Search for other papers by Yusuke Shimakawa in
Current site
Google Scholar
PubMed
Search for other papers by Yusuke Shimakawa in
Current site
Google Scholar
PubMed
Issiaka Bamba
Issiaka Bamba
Sciences de l'Homme Appliquées au Développement et à l'Evaluation des Interventions (SHADEI), Centre Muraz, Bobo-Dioulasso, Burkina Faso.
Search for other papers by Issiaka Bamba in
Current site
Google Scholar
PubMed
Search for other papers by Issiaka Bamba in
Current site
Google Scholar
PubMed
Abdoulaye Traoré
Abdoulaye Traoré
Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
Search for other papers by Abdoulaye Traoré in
Current site
Google Scholar
PubMed
Search for other papers by Abdoulaye Traoré in
Current site
Google Scholar
PubMed
Abstract
Hepatitis B virus (HBV) infection is a critical global health problem. The World Health Organization (WHO) has recently developed a global elimination strategy for HBV infection. Increasing access to screening, liver assessment, and antiviral treatment are crucial steps in achieving this goal. Little is known, however, about obstacles to linkage to care in low- and middle-income countries. Using a grounded theory approach, this qualitative study sought to characterize the diagnostic itineraries of people with chronic HBV infection in Burkina Faso, a west African country with high HBV prevalence, to identify barriers to linkage from screening to specialist care with hepatic assessment (alanine transaminase and hepatitis B e antigen or HBV DNA). We conducted 80 semistructured interviews with chronically infected people, their families, medical personnel, and traditional practitioners, and participant observation of HBV diagnostic announcements and consultations. Of 30 individuals diagnosed with chronic viral hepatitis, 18 inadvertently discovered their status through blood screening and 12 actively sought diagnosis for their symptoms. Only a quarter (8/30) were linked to care. Barriers included: 1) patients' ability to pay for testing and treatment; 2) a formal health system lacking trained personnel, diagnostic infrastructures, and other resources; 3) patients' familial and social networks that discouraged access to testing and HBV knowledge; 4) a well-developed demand for and provisioning of traditional medicine for hepatitis; and 5) a weak global politics around HBV. More training for medical personnel would improve linkage to care in sub-Saharan Africa. Developing effective communications between medical workers and patients should be a major priority in this elimination strategy.
Author Notes
Financial support: This study was funded in full by the Agence Nationale de la Recherches sur le SIDA et les Hépatites (ANRS), study number ANRS 12258.
Authors' addresses: Tamara Giles-Vernick and Yusuke Shimakawa, Emerging Diseases Epidemiology Unit, Pasteur Institute, Montpellier, France, E-mails: tamara.giles-vernick@pasteur.fr and yusuke.shimakawa@pasteur.fr. Fabienne Hejoaka, Unité Mixte Internationale (UMI) 233/U1175 TransVIH, Institut de Recherche pour le Développement/Institut National de la Santé et de la Recherche Médicale (INSERM), Montpellier, France, E-mail: fabienne.hejoaka@ird.fr. Armande Sanou and Abdoulaye Traoré, Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso, E-mails: armandsanou@yahoo.fr and traoreabdou.gras@fasonet.bf. Issiaka Bamba, Sciences de l'Homme Appliquées au Développement et à l'Evaluation des Interventions (SHADEI), Centre Muraz, Bobo-Dioulasso, Burkina Faso, E-mail: bamba_issiaka2006@yahoo.fr.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
WHO, 2015. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. Geneva, Switzerland: World Health Organization. Available at: http://apps.who.int/iris/bitstream/10665/154590/1/9789241549059_eng.pdf?ua=1. Accessed March 16, 2015.
-
2.
Shimakawa Y, Lemoine M, Njai HF, Bottomley C, Ndow G, Goldin RD, Jatta A, Jeng-Barry A, Wegmuller R, Moore SE, 2015. Natural history of chronic HBV infection in west Africa: a longitudinal population-based study from The Gambia. Gut gutjnl-2015-309892.
-
3.
El-Serag H, 2011. Hepatocellular cancer. N Engl J Med 365: 1118–1127.
-
4.
Lemoine M, Eholié S, Lacombe K, 2015. Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach. J Hepatol 62: 469–476.
-
5.
Stockdale AJ, Geretti AM, 2015. Chronic hepatitis B infection in sub-Saharan Africa: a grave challenge and a great hope. Trans R Soc Trop Med Hyg 109: 421–422.
-
6.
Samuelsen H, 2001. Infusions of health: the popularity of vaccinations among Bissa in Burkina Faso. Anthropol Med 8: 163–175.
-
7.
Leach MA, Fairhead JR, Millimouno D, Diallo AA, 2008. New therapeutic landscapes in Africa: parental categories and practices in seeking infant health in the Republic of Guinea. Soc Sci Med 66: 2157–2167.
-
8.
Carruth L, 2014. Camel milk, amoxicillin, and a prayer: medical pluralism and medical humanitarian aid in the Somali Region of Ethiopia. Soc Sci Med 120: 405–412.
-
9.
Pourette D, Enel C, 2014. Représentations et vécu de l'hépatite B de patients subsahariens en Côte d'Ivoire et en France: representations and disease experience of hepatitis B by Sub-Saharan patients in Ivory Coast and France. Santé Publique 26: 869–878.
-
10.
Mkandawire P, Richmond C, Dixon J, Luginaah IN, Tobias J, 2013. Hepatitis B in Ghana's upper west region: a hidden epidemic in need of national policy attention. Health Place 23: 89–96.
-
11.
Blanas DA, Nichols K, Bekele M, Shankar H, Bekele S, Jandorf L, Izzeldin S, Ndiaye D, Traore A, Bassam M, 2015. Adapting the Andersen model to a francophone west African immigrant population: hepatitis B screening and linkage to care in New York City. J Community Health 40: 175–184.
-
12.
Cheng A, Jose J, Larsen-Reindorf R, Small C, Nde H, Dugas L, Ehrhardt S, Nelson K, Ezeanolue E, Layden J, 2015. A survey study of pregnant women and healthcare practitioners assessing the knowledge of attitudes and practices of hepatitis B management at a teaching hospital in Kumasi, Ghana, west Africa. Open Forum Infect Dis 2: ofv122.
-
13.
Pourette D, 2013. Prise en charge du VIH et de l'hépatite B chronique chez les migrants subsahariens en France: le rôle-clé de la relation médecin-patient. Santé Publique 25: 561–570.
-
14.
Abeje G, Azage M, 2015. Hepatitis B vaccine knowledge and vaccination status among health care workers of Bahir Dar City Administration, northwest Ethiopia: a cross sectional study. BMC Infect Dis 15: 1.
-
15.
Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ, 2015. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386: 1546–1555.
-
16.
Ridde V, Carabali M, Ly A, Druetz T, Kouanda S, Bonnet E, Haddad S, 2014. The need for more research and public health interventions on dengue fever in Burkina Faso. PLoS Negl Trop Dis 8: e2859.
-
17.
Ridde V, 2008. “The problem of the worst-off is dealt with after all other issues”: the equity and health policy implementation gap in Burkina Faso. Soc Sci Med 66: 1368–1378.
-
18.
INSD, 2013. Population Des Principales Villes. Available at: http://www.insd.bf/n/contenu/Tableaux/T0314.htm. Accessed December 20, 2015.
-
19.
INSD, 2013. Annuaire Statistique. Ouagadougou: Ministère de l'Économie et des Finances. Available at: http://www.insd.bf/n/contenu/pub_periodiques/annuaires_stat/Annuaires_stat_nationaux_BF/Annuaire_stat_2013.pdf. Accessed December 20, 2015.
-
20.
Bonnard P, Sombié R, Lescure F-X, Bougouma A, Guiard-Schmid JB, Poynard T, Calès P, Housset C, Callard P, Le Pendeven C, 2010. Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso. Am J Trop Med Hyg 82: 454–458.
-
21.
Charmaz K, 2006. Constructing Grounded Theory: A Practical Guide Through Qualitative Analysis London: Sage.
-
22.
Giles-Vernick T, Traore A, Sirima SB, 2011. Malaria, environmental change, and a historical epidemiology of childhood ‘cold fevers’: popular interpretations from southwestern Burkina Faso. Health Place 17: 836–842.
-
23.
Dugas M, Dubé E, Bibeau G, 2009. Translating malaria as sumaya: justified convention or inappropriateness? Anthropol Med 16: 307–318.
-
24.
World Bank, 2015. World Development Report. Available at: http://data.worldbank.org/country/burkina-faso. Accessed March 18, 2016.
-
25.
Gulliford M, Figueroa-Munoz J, Morgan M, Hughes D, Gibson B, Beech R, Hudson M, 2002. What does ‘access to health care' mean? J Health Serv Res Policy 7: 186–188.
-
26.
Debes J, Kayandabila J, Pogemiller H, 2016. Knowledge of hepatitis B transmission risks among health workers in Tanzania. Am J Trop Med Hyg 94: 1100–1102.
-
27.
Fontein J, 2011. Graves, ruins, and belonging: towards an anthropology of proximity. J R Anthropol Inst 17: 706–727.
-
28.
Brown H, Kelly AH, 2014. Material proximities and hotspots: toward an anthropology of viral hemorrhagic fevers. Med Anthropol Q 28: 280–303.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 438 | 358 | 32 |
| Full Text Views | 576 | 14 | 1 |
| PDF Downloads | 204 | 11 | 1 |